65
Views
213
CrossRef citations to date
0
Altmetric
Article

CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells

, , , , , , , , , , , & show all
Pages 2955-2964 | Received 16 Sep 2005, Accepted 21 Jan 2006, Published online: 27 Mar 2023

REFERENCES

  • Aubin, J. E. 2001. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2:81–94.
  • Baker, J. C., R. S. Beddington, and R. M. Harland. 1999. Wnt signaling in Xenopus embryos inhibits bmp4 expression and activates neural development. Genes Dev. 13:3149–3159.
  • Bergwitz, C., T. Wendlandt, A. Kispert, and G. Brabant. 2001. Wnts differentially regulate colony growth and differentiation of chondrogenic rat calvaria cells. Biochim. Biophys. Acta 1538:129–140.
  • Blom, I. E., R. Goldschmeding, and A. Leask. 2002. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol. 21:473–482.
  • Boyden, L. M., J. Mao, J. Belsky, L. Mitzner, A. Farhi, M. A. Mitnick, D. Wu, K. Insogna, and R. P. Lifton. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346:1513–1521.
  • Brigstock, D. R. 2003. The CCN family: a new stimulus package. J. Endocrinol. 178:169–175.
  • Brigstock, D. R., R. Goldschmeding, K. I. Katsube, S. C. Lam, L. F. Lau, K. Lyons, C. Naus, B. Perbal, B. Riser, M. Takigawa, and H. Yeger. 2003. Proposal for a unified CCN nomenclature. Mol. Pathol. 56:127–128.
  • Cadigan, K. M., and R. Nusse. 1997. Wnt signaling: a common theme in animal development. Genes Dev. 11:3286–3305.
  • Capdevila, J., and J. Izpisua Belmonte. 2001. Patterning mechanisms controlling vertebrate limb development. Annu. Rev. Cell Dev. Biol. 17:87–132.
  • Caplan, A. I., and S. P. Bruder. 2001. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7:259–264.
  • Cheng, H., W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. Breyer, P. Vanichakarn, J. P. Szatkowski, J. Y. Park, and T. C. He. 2003. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. Am. 85-A:1544–1552.
  • Cheng, S. L., J. S. Shao, N. Charlton-Kachigian, A. P. Loewy, and D. A. Towler. 2003. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J. Biol. Chem. 278:45969–45977.
  • Christian, J. L. 2000. BMP, Wnt and Hedgehog signals: how far can they go? Curr. Opin. Cell Biol. 12:244–249.
  • Date, T., Y. Doiguchi, M. Nobuta, and H. Shindo. 2004. Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro. J. Orthop. Sci. 9:503–508.
  • Derfoul, A., A. L. Carlberg, R. S. Tuan, and D. J. Hall. 2004. Differential regulation of osteogenic marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells. Differentiation 72:209–223.
  • Ducy, P., T. Schinke, and G. Karsenty. 2000. The osteoblast: a sophisticated fibroblast under central surveillance. Science 289:1501–1504.
  • Fischer, L., G. Boland, and R. S. Tuan. 2002. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J. Biol. Chem. 277:30870–30878.
  • Fischer, L., G. Boland, and R. S. Tuan. 2002. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J. Cell. Biochem. 84:816–831.
  • Gong, Y., R. B. Slee, N. Fukai, G. Rawadi, S. Roman-Roman, A. M. Reginato, H. Wang, T. Cundy, F. H. Glorieux, D. Lev, M. Zacharin, K. Oexle, J. Marcelino, W. Suwairi, S. Heeger, G. Sabatakos, S. Apte, W. N. Adkins, J. Allgrove, M. Arslan-Kirchner, J. A. Batch, P. Beighton, G. C. Black, R. G. Boles, L. M. Boon, C. Borrone, H. G. Brunner, G. F. Carle, B. Dallapiccola, A. De Paepe, B. Floege, M. L. Halfhide, B. Hall, R. C. Hennekam, T. Hirose, A. Jans, H. Juppner, C. A. Kim, K. Keppler-Noreuil, A. Kohlschuetter, D. LaCombe, M. Lambert, E. Lemyre, T. Letteboer, L. Peltonen, R. S. Ramesar, M. Romanengo, H. Somer, E. Steichen-Gersdorf, B. Steinmann, B. Sullivan, A. Superti-Furga, W. Swoboda, M. J. van den Boogaard, W. Van Hul, M. Vikkula, M. Votruba, B. Zabel, T. Garcia, R. Baron, B. R. Olsen, and M. L. Warman. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523.
  • Hartmann, C., and C. J. Tabin. 2000. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127:3141–3159.
  • Haydon, R. C., A. Deyrup, A. Ishikawa, R. Heck, W. Jiang, L. Zhou, T. Feng, D. King, H. Cheng, B. Breyer, T. Peabody, M. A. Simon, A. G. Montag, and T. C. He. 2002. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int. J. Cancer 102:338–342.
  • He, T. C., T. A. Chan, B. Vogelstein, and K. W. Kinzler. 1999. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335–345.
  • He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512.
  • He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
  • Hoppler, S., and R. T. Moon. 1998. BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech. Dev. 71:119–129.
  • Kang, Q., M. H. Sun, H. Cheng, Y. Peng, A. G. Montag, A. T. Deyrup, W. Jiang, H. H. Luu, J. P. Szatkowski, P. Vanichakarn, J. Y. Park, J. Luo, Y. Li, R. C. Haydon, and T.-C. He. 2004. Characterization of the distinct orthotopic bone forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 11:1312–1320.
  • Labbe, E., A. Letamendia, and L. Attisano. 2000. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc. Natl. Acad. Sci. USA 97:8358–8363.
  • Lam, S., R. N. van der Geest, N. A. Verhagen, F. A. van Nieuwenhoven, I. E. Blom, J. Aten, R. Goldschmeding, M. R. Daha, and C. van Kooten. 2003. Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 52:2975–2983.
  • Latinkic, B. V., S. Mercurio, B. Bennett, E. M. Hirst, Q. Xu, L. F. Lau, T. J. Mohun, and J. C. Smith. 2003. Xenopus Cyr61 regulates gastrulation movements and modulates Wnt signalling. Development 130:2429–2441.
  • Lau, L. F., and S. C. Lam. 1999. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 248:44–57.
  • Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98:31–36.
  • Lin, X. 2004. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131:6009–6021.
  • Little, R. D., J. P. Carulli, R. G. Del Mastro, J. Dupuis, M. Osborne, C. Folz, S. P. Manning, P. M. Swain, S. C. Zhao, B. Eustace, M. M. Lappe, L. Spitzer, S. Zweier, K. Braunschweiger, Y. Benchekroun, X. Hu, R. Adair, L. Chee, M. G. FitzGerald, C. Tulig, A. Caruso, N. Tzellas, A. Bawa, B. Franklin, S. McGuire, X. Nogues, G. Gong, K. M. Allen, A. Anisowicz, A. J. Morales, P. T. Lomedico, S. M. Recker, P. Van Eerdewegh, R. R. Recker, and M. L. Johnson. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet. 70:11–19.
  • Luo, Q., Q. Kang, W. Si, W. Jiang, J. K. Park, Y. Peng, X. Li, H. H. Luu, J. Luo, A. G. Montag, R. C. Haydon, and T. C. He. 2004. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279:55958–55968.
  • Luu, H. H., Q. Kang, J. K. Park, W. Si, Q. Luo, W. Jiang, H. Yin, A. G. Montag, M. A. Simon, T. D. Peabody, R. C. Haydon, C. W. Rinker-Schaeffer, and T.-C. He. 2005. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 22:319–329.
  • Luu, H. H., L. Zhou, R. C. Haydon, A. T. Deyrup, A. G. Montag, D. Huo, R. Heck, C. W. Heizmann, T. Peabody, M. A. Simon, and T.-C. He. 2005. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 229:135–148.
  • Mo, F. E., A. G. Muntean, C. C. Chen, D. B. Stolz, S. C. Watkins, and L. F. Lau. 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 22:8709–8720.
  • Moussad, E. E., and D. R. Brigstock. 2000. Connective tissue growth factor: what's in a name? Mol. Genet. Metab. 71:276–292.
  • Nelson, W. J., and R. Nusse. 2004. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483–1487.
  • Nishita, M., M. K. Hashimoto, S. Ogata, M. N. Laurent, N. Ueno, H. Shibuya, and K. W. Cho. 2000. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403:781–785.
  • O'Brien, T. P., G. P. Yang, L. Sanders, and L. F. Lau. 1990. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol. Cell. Biol. 10:3569–3577.
  • Olsen, B. R., A. M. Reginato, and W. Wang. 2000. Bone development. Annu. Rev. Cell Dev. Biol. 16:191–220.
  • Peng, Y., Q. Kang, H. Cheng, X. Li, M. H. Sun, W. Jiang, H. H. Luu, J. Y. Park, R. C. Haydon, and T. C. He. 2003. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J. Cell. Biochem. 90:1149–1165.
  • Peng, Y., Q. Kang, Q. Luo, W. Jiang, W. Si, B. A. Liu, H. H. Luu, J. K. Park, X. Li, J. Luo, A. G. Montag, R. C. Haydon, and T. C. He. 2004. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J. Biol. Chem. 279:32941–32949.
  • Pennica, D., T. A. Swanson, J. W. Welsh, M. A. Roy, D. A. Lawrence, J. Lee, J. Brush, L. A. Taneyhill, B. Deuel, M. Lew, C. Watanabe, R. L. Cohen, M. F. Melhem, G. G. Finley, P. Quirke, A. D. Goddard, K. J. Hillan, A. L. Gurney, D. Botstein, and A. J. Levine. 1998. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95:14717–14722.
  • Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet 363:62–64.
  • Perrimon, N., and M. Bernfield. 2000. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404:725–728.
  • Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147.
  • Planque, N., and B. Perbal. 2003. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 3:15.
  • Shtutman, M., J. Zhurinsky, I. Simcha, C. Albanese, M. D'Amico, R. Pestell, and A. Ben-Ze'ev. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 96:5522–5527.
  • Tang, Q. Q., T. C. Otto, and M. D. Lane. 2004. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. USA 101:9607–9611.
  • Tetsu, O., and F. McCormick. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426.
  • Tian, E., F. Zhan, R. Walker, E. Rasmussen, Y. Ma, B. Barlogie, and J. D. Shaughnessy, Jr. 2003. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N. Engl. J. Med. 349:2483–2494.
  • Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116–5121.
  • Urist, M. R., O. Nilsson, J. Rasmussen, W. Hirota, T. Lovell, T. Schmalzreid, and G. A. Finerman. 1987. Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin. Orthop. 214:295–304.
  • Wodarz, A., and R. Nusse. 1998. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14:59–88.
  • Wozney, J. M., V. Rosen, A. J. Celeste, L. M. Mitsock, M. J. Whitters, R. W. Kriz, R. M. Hewick, and E. A. Wang. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534.
  • Xu, L., R. B. Corcoran, J. W. Welsh, D. Pennica, and A. J. Levine. 2000. WISP-1 is a wnt-1- and beta-catenin-responsive oncogene. Genes Dev. 14:585–595.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.